银休特 PODD 深 沪
等待开盘 04-01 09:30:00 美东时间
209.84
+1.830
+0.88%
华盛通- 最 高212.92
- 今 开210.81
- 成交量 75.17万股
- 最 低 206.55
- 昨 收 208.01
- 总市值 147.72亿
- 52周最高 354.88
- 市盈率 静 60.31
- 换手率 1.07%
- 52周最低 205.11
- 委 比 94.86%
- 总股本 7039.58万
- 历史最高 354.88
- 量 比 0.85
- 振 幅 3.06%
- 历史最低 14.00
- 每 手 1
- 风险率 34.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Insulet names Mike Panos chief commercial officer
Insulet names Mike Panos chief commercial officer Insulet appointed Mike Panos as executive vice president, chief commercial officer, effective immediately. Panos will lead global commercial organization, reporting to CEO Ashley McEvoy. He most recently led sales excellence at Stryker. Panos spent 3
03-30 20:30
Notable healthcare headlines for the week: Merck, Medtronic, and Novartis in focus
U.S. stocks ended Friday broadly lower, with selling pressure intensifying across sectors as investors weighed persistent geopolitical risks tied to tensions in the Middle East. The tech-focused Nasda...
03-29 21:05
EXCLUSIVE: Just 5 Female CEOs In A 50-Stock ETF — C-Suite Execs Explain The Leadership Gap In Corporate America (CORRECTED)
Women remain scarce in the C‑suite, with only a fraction of large U.S. companies led by female CEOs. A leadership‑focused ETF highlights how rare top‑level gender representation still is.
03-17 19:37
Insulet Stock Hits 52-Week Low - Here's Why
Insulet shares fall after the company warns certain Omnipod 5 Pods may under-deliver insulin, linked to reports of serious health events.
03-13 21:45
Insulet recalling certain defective Omnipod insulin delivery devices
Insulet Corporation (PODD) has initiated a voluntary recall of certain lots of its Omnipod 5 insulin delivery Pods in the U.S. after detecting that some devices had a manufacturing defect that causes ...
03-13 20:41
美股盘后 | Equinox Gold Corp.涨4.73%，EOG能源涨2.02%
Equinox Gold Corp.涨4.73%；EOG能源涨2.02%；Teck Resources Limited Class B涨2.01%
03-13 06:11
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Citigroup Maintains Buy on Insulet, Lowers Price Target to $338
Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $345 to $338.
03-11 23:41
Insulet to present Omnipod fully closed-loop EVOLUTION 2 results at ATTD 2026
Insulet to present Omnipod fully closed-loop EVOLUTION 2 results at ATTD 2026 Insulet will attend the 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), running March 11–14, 2026 in Barcelona and online. The company will hold an Insulet symposium on March 11, 20
03-10 19:03
